PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 7 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $512,000 | +1.8% | 500,000 | 0.0% | 0.02% | +4.5% |
Q2 2021 | $503,000 | +2.7% | 500,000 | 0.0% | 0.02% | -4.3% |
Q1 2021 | $490,000 | +3.4% | 500,000 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $474,000 | +3.0% | 500,000 | 0.0% | 0.02% | -28.1% |
Q3 2020 | $460,000 | +3.6% | 500,000 | 0.0% | 0.03% | +23.1% |
Q2 2020 | $444,000 | – | 500,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,914,000 | $22,064,000 | 0.88% |
WHITEBOX ADVISORS LLC | 5,000,000 | $4,857,000 | 0.16% |
ANGELO GORDON & CO., L.P. | 1,397,000 | $1,357,000 | 0.12% |
UBS OCONNOR LLC | 8,000,000 | $7,840,000,000 | 0.11% |
INGALLS & SNYDER LLC | 500,000 | $490,000 | 0.02% |
CITIGROUP INC | 7,832,000 | $7,608,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |